Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
169.06
154.69
125.25
149.71
141.52
126.67
110.40
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
169.06
154.69
125.25
149.71
141.52
126.67
110.40
Raw Material Cost
21.34
17.07
13.54
16.88
15.45
13.44
15.72
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.71
11.56
11.46
11.96
12.69
12.51
12.44
Selling and Distribution Expenses
90.04
84.54
91.83
86.67
75.11
73.58
88.03
Other Expenses
1.17
4.93
1.64
1.82
1.35
1.22
1.59
Total Expenditure (Excl Depreciation)
134.79
162.46
133.20
133.74
116.72
111.70
132.08
Operating Profit (PBDIT) excl Other Income
34.300000000000004
-7.800000000000001
-8
16
24.8
15
-21.7
Other Income
11.72
1.86
1.36
3.92
-2.18
-2.35
-3.43
Operating Profit (PBDIT)
47.86
-4.06
-4.75
21.93
24.79
14.80
-22.95
Interest
11.71
11.56
11.46
11.96
12.69
12.51
12.44
Exceptional Items
0.00
-1.70
0.00
0.00
-3.14
0.00
-6.04
Gross Profit (PBDT)
147.72
137.62
111.71
132.83
126.07
113.23
94.68
Depreciation
1.87
1.85
1.84
2.04
2.17
2.18
2.15
Profit Before Tax
34.27
-19.18
-18.05
7.93
6.79
0.11
-43.58
Tax
16.97
5.24
3.64
-6.80
13.51
15.80
4.84
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.31
-24.42
-21.69
14.74
-6.73
-15.70
-48.42
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.31
-24.42
-21.69
14.74
-6.73
-15.70
-48.42
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.31
-24.42
-21.69
14.74
-6.73
-15.70
-48.42
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
230.42
204.30
193.56
194.04
178.82
132.52
130.69
Earnings per share (EPS)
0.06
-0.08
-0.07
0.05
-0.02
-0.05
-0.16
Diluted Earnings per share
0.06
-0.08
-0.07
0.05
-0.02
-0.05
-0.16
Operating Profit Margin (Excl OI)
20.27%
-5.02%
-6.35%
10.67%
17.53%
11.82%
-19.63%
Gross Profit Margin
21.38%
-11.2%
-12.94%
6.66%
6.33%
1.81%
-37.53%
PAT Margin
10.24%
-15.79%
-17.31%
9.85%
-4.75%
-12.39%
-43.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 19.51% vs 36.71% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 358.21% vs 68.98% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 33.70% vs 310.94% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -7.87% vs -2.31% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Amicus Therapeutics, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
169.06
0.00
169.06
Other Operating Income
0.00
0.00
0.00
Total Operating income
169.06
0.00
169.06
Raw Material Cost
21.34
1.54
19.80
1,285.71%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
11.71
2.65
9.06
341.89%
Selling and Distribution Expenses
90.04
34.69
55.35
159.56%
Other Expenses
1.17
10.38
-9.21
-88.73%
Total Expenditure (Excl Depreciation)
134.79
142.66
-7.87
-5.52%
Operating Profit (PBDIT) excl Other Income
34.27
-142.66
176.93
124.02%
Other Income
11.72
14.45
-2.73
-18.89%
Operating Profit (PBDIT)
47.86
-126.67
174.53
137.78%
Interest
11.71
2.65
9.06
341.89%
Exceptional Items
0.00
-0.91
0.91
100.00%
Gross Profit (PBDT)
147.72
-1.54
149.26
9,692.21%
Depreciation
1.87
1.54
0.33
21.43%
Profit Before Tax
34.27
-131.77
166.04
126.01%
Tax
16.97
0.14
16.83
12,021.43%
Provisions and contingencies
0
0
0.00
Profit After Tax
17.31
-131.91
149.22
113.12%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
17.31
-131.91
149.22
113.12%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.31
-131.91
149.22
113.12%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
230.42
564.46
-334.04
-59.18%
Earnings per share (EPS)
0.06
-0.73
0.79
108.22%
Diluted Earnings per share
0.06
-0.73
0.79
108.22%
Operating Profit Margin (Excl OI)
20.27%
0.00%
0.00
20.27%
Gross Profit Margin
21.38%
0.00%
0.00
21.38%
PAT Margin
10.24%
0.00%
0.00
10.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 16.91 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 9.31% vs 23.56% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 19.51% vs 36.71% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.73 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 170.90% vs -12.44% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 358.21% vs 68.98% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.61 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 711.86% vs 3.28% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 33.70% vs 310.94% in Sep 2024
Quarterly - Interest
Interest 1.17 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 0.86% vs 0.87% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -7.87% vs -2.31% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.27%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
